Body weight, plasma insulin, and coronary events with gemfibrozil in the Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT).
about
Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan studyDiabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategiesEffect of dietary fatty acid composition on food intake, triglycerides, and hypothalamic peptidesThe prognostic importance of weight loss in coronary artery disease: a systematic review and meta-analysis.
P2860
Body weight, plasma insulin, and coronary events with gemfibrozil in the Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT).
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Body weight, plasma insulin, a ...... n Intervention Trial (VA-HIT).
@en
Body weight, plasma insulin, a ...... n Intervention Trial (VA-HIT).
@nl
type
label
Body weight, plasma insulin, a ...... n Intervention Trial (VA-HIT).
@en
Body weight, plasma insulin, a ...... n Intervention Trial (VA-HIT).
@nl
prefLabel
Body weight, plasma insulin, a ...... n Intervention Trial (VA-HIT).
@en
Body weight, plasma insulin, a ...... n Intervention Trial (VA-HIT).
@nl
P2093
P1433
P1476
Body weight, plasma insulin, a ...... in Intervention Trial (VA-HIT)
@en
P2093
Dorothea Collins
Judith R McNamara
Sander J Robins
P304
P356
10.1016/J.ATHEROSCLEROSIS.2007.01.029
P577
2007-03-01T00:00:00Z